(877) 505-4777| info@speakersnetwork.com

Infectious Diseases

Medical Director, Healthcare Epidemiology, Infection Prevention and Control
Professor of Medicine, Division of Infectious Diseases

Antimicrobial Therapy Update: New Drugs for Resistant Bugs
Enhancing Patient Safety by the Prevention and Control of Healthcare-Associated Infections
Antimicrobial Resistance: From the Farm to the Bedside
Resistant Gram-Positive Infections: Focus on MRSA and CA-MRSA
Pandemic, Avian, and Seasonal Influenza
Pneumonia: Making Sense of the Guidelines
Bloodborne Pathogens: What the Healthcare Worker Should Know
Sepsis: Pathogens, Pathogenesis, and Treatment
Complicated Skin Infections: Prevention and Management
Clostridium Difficile Infection
SuperBugs: Virulence and Resistance Mechanism in Gram Negative Bacteria
Prevention of Management of CAUTI

He is a fantastic speaker. – Parkview Medical Center I am so very happy you were able to schedule this speaker for one of our November dates. He is the very best speaker and I don’t know what I will do without him being available in the future. We’ve used him often and he always receives excellent reviews. The Univ. of Penn. is very lucky to have him!! – Torrance Memorial Medical Center

Chief, Infectious Disease Service
Associate Professor of Clinical Medicine

Perilous Pets: Modern Zoonoses / Pet Associated Infection
Infectious Disease Update: Legionnaire’s Disease, Chikungunya, West Nile Virus etc.
Time Out for Ticks: Tick-borne Disease in Los Angeles
Trouble in Paradise: Travel Medicine Update
Ebola Viral Infection: What Doctors and Hospitals Need to Know
ID Dermal Dilemmas: Antibiotic-Associated Skin Rash
Bugs and Drugs: Antibiotic Therapy 2016
Central Nervous System Infections Including West Nile Virus
Infections of Mexico and Central America
Malaria: Pearls and Pitfalls for the Houseofficer
Antibiotic Resistance
Parasitic Infections in HIV+ Patients
History of Penicillin: Lessons for the Houseofficer

Good at-ease speaker with light humorous touch- Providence Holy Cross Medical Center

Associate Chief, Adult Infectious Diseases
Senior Investigator
Vice Chair, Academic Affairs
LA Biomedical Research Institute
Professor of Medicine
David Geffen School of Medicine at UCLA

Infective Endocarditis
Prophylaxis of Endocarditis

In a faculty career spanning more than 30 years, Dr. Arnold Bayer has dedicated himself to deepening our understanding of infectious disease. He continues to study the ways in which the human body responds to infection and builds up resistance to antibiotics, with an ultimate goal of developing strategies for effectively fighting off pathogens.With funding from both NIH/NIAID and private sector pharmaceutical sources, Dr. Bayer is conducting research related to the mechanisms by which platelet peptides kill common blood stream pathogens, as well as to the study of the genetic mechanisms by which certain strains of bacteria develop resistance and cross-resistance to antibiotics.In addition to his numerous responsibilities within the Harbor-UCLA Medical Center community, Dr. Bayer plays an active role in the international medical and academic spheres. A co-author of well over 200 scientific papers, book chapters and major reviews and a frequent lecturer and presenter on topics concerning infectious disease, Dr. Bayer has served on national committees, including the National American Heart Associations Committee on Rheumatic Fever, Endocarditis & Kawasakis Disease; NIAIDs National Association for Research in Staphylococcus aureus (NARSA); and, the International Society on Cardiovascular Infectious Diseases (ISCVID). He is a charter committee member of the International Consortium for the Study of Infective Endocarditis (ICE) and he also serves as ongoing principal investigator and steering committee member for the Consortiums UCLA site.Dr. Bayer began his medical education on the East coast, earning his degree from Temple University School of Medicine in Philadelphia, Pennsylvania. After completing an internship and junior residency program at Thomas Jefferson University Hospital, also in Philadelphia, Dr. Bayer came to Harbor-UCLA Medical Center as a senior resident in Internal Medicine, and a Clinical-Research Fellow in infectious diseases. Immediately thereafter, he began post-doctoral research fellowship in infectious diseases at Wadsworth VA Medical Center in Los Angeles, CA, before joining the faculty at Harbor-UCLA and LA Biomed.

Vice Chair, Quality Improvement
Professor of Medicine
Hospital Epidemiologist and Director of Infection Control
Medical University of South Carolina

Hospital Epidemiology
Infection Control
Antibiotic Resistance
HIV Care


Director, RM Alden Research Laboratory
Clinical Editor, Clinical Infectious Diseases
Clinical Professor of Medicine
David Geffen School of Medicine at UCLA

Antibiotic Stewardship
Proper Use of Carbapenems in the Era of Resistance
C Difficile
Probiotics and Diarrhea
Complicated UTIs
Anaerobic Infections
New Drugs
Skin and Soft Tissue Infections: The Times They Are Achanging


Professor, Division of Infectious Diseases
Departments of Internal Medicine and Microbiology
Director, Levitt Center for Viral Pathogenesis
University of Iowa

HIV / AIDS Update for the PCP
Hepatitis C


Chief, Infectious Diseases
Member, Hematologic Malignancies Program, Comprehensive Cancer Center
Professor of Medical Specialties
City of Hope National Medical Center

Swine Flu
Fever and NeutropeniaÊ


Aaron D. Miller and Edith Miller Chair in Gene Therapy
Institutional Official for Research
Professor of Pediatrics
City of Hope National Medical Center

CMV Immunology
Gene Therapy
Development of Hematopoietic Stem Cell Based Gene Therapy for HIV-1 Infection


Chief, Division of Infectious Diseases
Icahn School of Medicine at Mount Sinai

Cardiovascular Complications of HIV
Management of HIV Related Dyslipidemia
Primary Care of Persons Infected with HIV
Metabolic Complications of HIV
Drug Interactions Associated with Antiretroviral Therapy
Fungal Infections / Opportunistic Infections
HIV Testing and Policy


Assistant Professor of Medicine
University of Maryland School of Medicine

HIV: The Current State of the Epidemic and Projections into the Future
HIV Treatment Adherence and Support
HIV Treatment Update
HIV Prevention and Pre-Exposure Prophylaxis
HIV Screening and Testing in Healthcare Settings
Tobacco Use and Smoking Cessation
Anal Cancer Prevention in MSMS

Dr. Sowah received his medical education at the University of Ghana Medical School in Accra Ghana. As a student he was usually seen with like-minded individuals volunteering his time taking care of the under-served. He left Ghana in 2001 to study public health at the Johns Hopkins Bloomberg School of Public Health, where he completed the MPH degree. After his MPH Degree he had the opportunity of doing his residency in internal medicine at the Cook County Hospital in Chicago, IL. In Cook County, Leonard learned and experienced the rudiments of providing quality health care to a largely uninsured and under-insured population. This experience sparked in him a fire that drove him to take an interest in Health Care Policy.Dr. Sowah is an active member of the American College of Physicians and is very active in efforts by the College to advocate for legislation to improve the health care environment to the benefit of physicians and their patients. He is currently a member of the Baltimore HIV Planning Council, where he provides valuable assistance in deciding how Ryan White Dollars are applied to help control the HIV epidemic in Baltimore. Dr. Sowah believes equity is an indispensible ingredient in providing quality health care and as a clinical preceptor works passionately to instill that belief in all his students. He was recently recognized by his students when he received the Alpha Omega Alpha, Volunteer Faculty Award. Dr. Sowahs research interest is in the influence of social and cultural environments on health outcomes. He is currently working to initiate a anal cancer screening program for HIV positive patients within the UMMS clinics. Dr. Sowah has presented his work at various national and international meetings.